chr11-119097048-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001382.4(DPAGT1):​c.1177A>G​(p.Ile393Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.423 in 1,613,754 control chromosomes in the GnomAD database, including 147,791 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.39 ( 12160 hom., cov: 31)
Exomes 𝑓: 0.43 ( 135631 hom. )

Consequence

DPAGT1
NM_001382.4 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: -0.573

Publications

66 publications found
Variant links:
Genes affected
DPAGT1 (HGNC:2995): (dolichyl-phosphate N-acetylglucosaminephosphotransferase 1) The protein encoded by this gene is an enzyme that catalyzes the first step in the dolichol-linked oligosaccharide pathway for glycoprotein biosynthesis. This enzyme belongs to the glycosyltransferase family 4. This protein is an integral membrane protein of the endoplasmic reticulum. The congenital disorder of glycosylation type Ij is caused by mutation in the gene encoding this enzyme. [provided by RefSeq, Jul 2008]
DPAGT1 Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 13
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Genomics England PanelApp, G2P
  • DPAGT1-congenital disorder of glycosylation
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Orphanet, G2P
  • congenital myasthenic syndromes with glycosylation defect
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=7.635585E-6).
BP6
Variant 11-119097048-T-C is Benign according to our data. Variant chr11-119097048-T-C is described in ClinVar as Benign. ClinVar VariationId is 93728.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.625 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001382.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DPAGT1
NM_001382.4
MANE Select
c.1177A>Gp.Ile393Val
missense
Exon 9 of 9NP_001373.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DPAGT1
ENST00000354202.9
TSL:1 MANE Select
c.1177A>Gp.Ile393Val
missense
Exon 9 of 9ENSP00000346142.4
DPAGT1
ENST00000409993.6
TSL:2
c.1177A>Gp.Ile393Val
missense
Exon 11 of 11ENSP00000386597.2
DPAGT1
ENST00000867497.1
c.1177A>Gp.Ile393Val
missense
Exon 10 of 10ENSP00000537556.1

Frequencies

GnomAD3 genomes
AF:
0.390
AC:
59257
AN:
151838
Hom.:
12148
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.297
Gnomad AMI
AF:
0.487
Gnomad AMR
AF:
0.329
Gnomad ASJ
AF:
0.557
Gnomad EAS
AF:
0.642
Gnomad SAS
AF:
0.496
Gnomad FIN
AF:
0.393
Gnomad MID
AF:
0.430
Gnomad NFE
AF:
0.423
Gnomad OTH
AF:
0.425
GnomAD2 exomes
AF:
0.418
AC:
105048
AN:
251260
AF XY:
0.428
show subpopulations
Gnomad AFR exome
AF:
0.295
Gnomad AMR exome
AF:
0.256
Gnomad ASJ exome
AF:
0.573
Gnomad EAS exome
AF:
0.639
Gnomad FIN exome
AF:
0.385
Gnomad NFE exome
AF:
0.424
Gnomad OTH exome
AF:
0.434
GnomAD4 exome
AF:
0.426
AC:
622857
AN:
1461798
Hom.:
135631
Cov.:
57
AF XY:
0.429
AC XY:
311817
AN XY:
727210
show subpopulations
African (AFR)
AF:
0.291
AC:
9726
AN:
33480
American (AMR)
AF:
0.263
AC:
11751
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.574
AC:
14995
AN:
26134
East Asian (EAS)
AF:
0.625
AC:
24801
AN:
39700
South Asian (SAS)
AF:
0.482
AC:
41614
AN:
86256
European-Finnish (FIN)
AF:
0.387
AC:
20667
AN:
53404
Middle Eastern (MID)
AF:
0.461
AC:
2661
AN:
5766
European-Non Finnish (NFE)
AF:
0.423
AC:
470084
AN:
1111956
Other (OTH)
AF:
0.440
AC:
26558
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
23116
46231
69347
92462
115578
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14434
28868
43302
57736
72170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.390
AC:
59299
AN:
151956
Hom.:
12160
Cov.:
31
AF XY:
0.392
AC XY:
29121
AN XY:
74266
show subpopulations
African (AFR)
AF:
0.297
AC:
12319
AN:
41470
American (AMR)
AF:
0.329
AC:
5015
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
0.557
AC:
1933
AN:
3470
East Asian (EAS)
AF:
0.643
AC:
3314
AN:
5154
South Asian (SAS)
AF:
0.495
AC:
2382
AN:
4816
European-Finnish (FIN)
AF:
0.393
AC:
4141
AN:
10546
Middle Eastern (MID)
AF:
0.435
AC:
128
AN:
294
European-Non Finnish (NFE)
AF:
0.423
AC:
28720
AN:
67938
Other (OTH)
AF:
0.429
AC:
905
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1775
3550
5324
7099
8874
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
582
1164
1746
2328
2910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.423
Hom.:
69062
Bravo
AF:
0.381
TwinsUK
AF:
0.421
AC:
1560
ALSPAC
AF:
0.431
AC:
1662
ESP6500AA
AF:
0.297
AC:
1307
ESP6500EA
AF:
0.433
AC:
3723
ExAC
AF:
0.421
AC:
51147
Asia WGS
AF:
0.534
AC:
1859
AN:
3478
EpiCase
AF:
0.445
EpiControl
AF:
0.438

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
not specified (6)
-
-
2
DPAGT1-congenital disorder of glycosylation (2)
-
-
1
Acute intermittent porphyria (1)
-
-
1
Congenital disorder of glycosylation (1)
-
-
1
Congenital myasthenic syndrome 13 (1)
-
-
1
DPAGT1-congenital disorder of glycosylation;C3553645:Congenital myasthenic syndrome 13 (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.056
BayesDel_addAF
Benign
-0.61
T
BayesDel_noAF
Benign
-0.50
CADD
Benign
0.29
DANN
Benign
0.38
DEOGEN2
Benign
0.18
T
Eigen
Benign
-2.0
Eigen_PC
Benign
-2.0
FATHMM_MKL
Benign
0.026
N
LIST_S2
Benign
0.61
T
MetaRNN
Benign
0.0000076
T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
-0.17
N
PhyloP100
-0.57
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-0.36
N
REVEL
Benign
0.20
Sift
Benign
0.55
T
Sift4G
Benign
0.53
T
Polyphen
0.0
B
Vest4
0.0040
MPC
0.42
ClinPred
0.0019
T
GERP RS
-4.2
RBP_binding_hub_radar
0.92
RBP_regulation_power_radar
2.0
Varity_R
0.027
gMVP
0.23
Mutation Taster
=89/11
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs643788; hg19: chr11-118967758; COSMIC: COSV53827927; COSMIC: COSV53827927; API